Glutamine drink for insulin resistance and bowel symptoms
Part of Hormones & metabolism clinical trials.
This trial studies whether taking an oral glutamine supplement can improve insulin resistance and reduce bowel-related problems in people with obesity and irritable bowel syndrome. It may help your blood sugar regulation and digestive comfort if you meet the criteria.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–65 years
- Body mass index (BMI) 35 or higher (grade II or III obesity)
- Blood sugar fasting is in the insulin-resistance range: 1.0 to 1.25 g/L
- You have irritable bowel syndrome (IBS) based on Rome IV criteria
- You have normal liver and kidney function (no significant liver or kidney problems)
- You have not had bariatric or other digestive surgery in the past; not pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special drink that may help improve blood sugar levels and gut health in people with prediabetes. It could offer a simple way to manage blood sugar and potentially prevent diabetes.
This trial tests how protein supplements affect body weight in people who are either normal weight or overweight. The goal is to see if adding protein helps with weight management.
This trial tests whether a supplement called glutamine can help people with irritable bowel syndrome (IBS) who have increased gut permeability (leaky gut). It aims to see if taking glutamine improves digestive symptoms and quality of life.
This trial is testing if a dietary supplement can reduce symptoms of irritable bowel syndrome (IBS). You might qualify if you have been diagnosed with IBS, have moderate to severe symptoms, and are between 18 and 75 years old.
This trial tests if taking glutamine (a nutrient) as an oral supplement helps patients recover after surgery to remove stomach cancer. It aims to see if it improves healing and quality of life.
This Phase 3 trial tests whether adding glutamine plus L. reuteri can help prevent severe diarrhea caused by EGFR-targeted treatments in people with advanced non-small cell lung cancer. If it works, it could make treatment easier to tolerate and help you stay on the planned therapy.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.